Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1939]

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran

Dr Saeed Nemati - International Agency for Research on Cancer , Lyon, France

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran ( Dr Saeed Nemati - International Agency for Research on Cancer , Lyon, France )

30 minute infusion of isatuximab shows potential in newly diagnosed multiple...

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

Dr Ashley Rosko - The Ohio State University, Columbus, USA

Understanding cognitive impairment for elderly patients undergoing CAR T therapy ( Dr Ashley Rosko - The Ohio State University, Columbus, USA )

SIOG 2024: Updates in haematology

Dr Ashley Rosko - The Ohio State University, Columbus, USA

SIOG 2024: Updates in haematology ( Dr Ashley Rosko - The Ohio State University, Columbus, USA )

Expectations and priorities of older patients with cancer: the PRIORITY...

Dr Camille Chakiba - Institute Bergonié, Bordeaux, France

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study ( Dr Camille Chakiba - Institute Bergonié, Bordeaux, France )

Isa-VRd shows greater efficacy compared to VRd in intransplant-ineligible NDMM...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Isa-VRd shows greater efficacy compared to VRd in intransplant-ineligible NDMM patients ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Daratumumab-based maintenance regimens show favourable responses in ransplant...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Daratumumab-based maintenance regimens show favourable responses in ransplant-eligible NDMM ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Optimising benefit-risk and minimising impact on quality of life with BCMA...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Understanding the remaining unmet needs in a post ASCT NDMM setting

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway

Understanding the remaining unmet needs in a post ASCT NDMM setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )

Approaches to risk stratification in high risk myeloma

Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Approaches to risk stratification in high risk myeloma ( Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

Use of Bispecifics and CAR T cells in South America

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

Use of Bispecifics and CAR T cells in South America ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Tailored to fit: New approaches in transplant-ineligible NDMM

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France

Tailored to fit: New approaches in transplant-ineligible NDMM ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )

More from ecancer